Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Alkem Laboratories Ltd - 539523 - Results- Financial Results For Quarter And Year Ended March 31, 22

 In continuation of our letter dated 28th April, 2022 and pursuant to Regulation 30 read with Regulation 33 of the SEBI LODR (''Listing Regulations'') the Board of Directors of the Company, at its meeting held today, i.e. 13th May, 2022, has inter alia approved the Standalone and Consolidated Audited Financial Results for the quarter and financial year ended 31st March, 2022. Accordingly, we are enclosing herewith Standalone and Consolidated Audited Financial Results for the quarter and financial year ended 31st March, 2022 and the Auditor''s Report thereon. The Company hereby declares that the Auditors have expressed an unmodified opinion in the Audit Reports on Standalone and Consolidated Financial Results for the quarter and financial year ended 31st March, 2022. The meeting of the Board of Directors of the Company commenced at 11.00 A.M and concluded at 1.30 P.M. Kindly take the same on record.
13-05-2022
Bigul

Alkem Laboratories Ltd - 539523 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 13/5/2022

 Please find enclosed the outcome of the BM dated 13.5.22
13-05-2022
Bigul

Annual report for Alkem Laboratories Ltd. for FY-2022
13-05-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q4FY22 and FY22 financial results will be held on Friday, 13th May, 2022 at 4.00 P.M. Please find attached herewith the conference call details. Kindly take note of the same.
02-05-2022
Bigul

Alkem Laboratories Ltd - 539523 - Board to consider FY22 Results & Final Dividend on May 13, 2022

 Alkem Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 13, 2022, inter alia:1. To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2022; and2. To consider and recommend Final Dividend, if any, for the Financial Year ended March 31, 2022.
28-04-2022
Bigul

Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of Board Of Directors Of The Company Scheduled To Be Held On 13Th May, 2022.

 Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2022 ,inter alia, to consider and approve (i) to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2022; and (ii) to consider and recommend Final Dividend, if any, for the Financial Year ended 31st March, 2022. Kindly take note of the same.
28-04-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 This is to inform you that US FDA had conducted an inspection at the Company's Bioequivalence Center located at Taloja, Maharashtra from 11th April, 2022 to 14th April, 2022. At the end of the inspection, no Form 483 was issued. Kindly take note of the same.
14-04-2022
Bigul

Alkem Laboratories Ltd - 539523 - Compliances- Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2022.

 In terms of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Certificate received from Practising Company Secretary for the year ended 31st March, 2022. Kindly take the same on record.
13-04-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 This is to inform you that ISP Chile had conducted a GMP inspection at the Company's manufacturing facility located at Baddi, India from 06th April, 2022 to 12th April, 2022. At the end of the inspection, no observations critical to Good Manufacturing Practices were detected. Kindly take note of the same.
13-04-2022
Bigul

Alkem Laboratories Ltd - 539523 - Compliance Certificate For The Period Ended March, 2022

 With reference to the subject matter, please find enclosed herewith the Compliance Certificate under Regulation 7(3) SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, duly signed by the Compliance officer and the authorised representative of Link Intime India Pvt Ltd (RTA) for the year ended 31st March, 2022. Kindly take the same on your records.
11-04-2022
Next Page
Close

Let's Open Free Demat Account